Liver Metastasis Clinical Trial
Official title:
Radioactive Holmium Microspheres for the Treatment of Patients With Non-resectable Liver Metastases of Mixed Origin; a Single Center, Interventional, Non-randomized, Open Label, Safety Study.
The HEPAR study is aimed at determining the safety of radioactive holmium containing microspheres for the treatment of tumors in the liver. These microspheres will be administered by infusion in the liver artery using a arterial catheter in the femoral artery.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05524155 -
Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis
|
Phase 2 | |
| Recruiting |
NCT02632201 -
Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT01715402 -
Optimization of Health Expenditure in Liver Surgery
|
N/A | |
| Recruiting |
NCT01035385 -
Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC)
|
Phase 3 | |
| Recruiting |
NCT05098847 -
Cryoablation Combined With Sintilimab Plus Lenvatinib In Previously Treated Unresectable Liver Metastasis From Solid Tumors
|
Phase 2 | |
| Withdrawn |
NCT02651090 -
Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI
|
Phase 3 | |
| Withdrawn |
NCT01775280 -
Response of Hepatic Tumors to Radioembolization
|
Phase 2 | |
| Completed |
NCT00068068 -
Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases
|
Phase 2 | |
| Terminated |
NCT02453490 -
Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis
|
Phase 3 | |
| Recruiting |
NCT04622423 -
Advanced Therapies for Liver Metastases
|
||
| Completed |
NCT00892424 -
Sorafenib-RT Treatment for Liver Metastasis (SLIM)
|
Phase 1/Phase 2 | |
| Completed |
NCT00028405 -
Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors
|
Phase 1 | |
| Completed |
NCT03801915 -
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
|
Phase 2 | |
| Completed |
NCT02218801 -
A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program
|
||
| Completed |
NCT01834014 -
Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
|
N/A | |
| Completed |
NCT00083785 -
Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases
|
Phase 2 | |
| Active, not recruiting |
NCT03428477 -
EPA for Metastasis Trial 2
|
Phase 3 | |
| Completed |
NCT02316028 -
Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)
|
Phase 1/Phase 2 | |
| Completed |
NCT01785212 -
The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver
|
N/A | |
| Completed |
NCT03785210 -
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
|
Phase 2 |